METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Clinical trials for METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New weapon against deadly prostate cancer enters final testing
Disease control Recruiting nowThis study is testing whether a new drug called pasritamig can help men live longer with advanced prostate cancer that has spread and no longer responds to standard hormone treatments. About 663 participants will receive either pasritamig plus standard supportive care or a placeb…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New immune weapon tested against advanced prostate cancer
Disease control Recruiting nowThis early-stage study is testing a new drug, JNJ-78278343, that aims to guide the body's own immune cells to attack prostate cancer. It is being given in combination with other standard treatments like immunotherapy, chemotherapy, or hormone therapy. The main goals are to find a…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC